Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001973204-23-000001
Filing Date
2023-06-02
Accepted
2023-06-02 18:54:35
Documents
1
Period of Report
2023-06-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 5689
  Complete submission text file 0001973204-23-000001.txt   7378
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
Aspira Women's Health Inc. (Issuer) CIK: 0000926617 (see all company filings)

EIN.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 6331 LAVENDALE AVE DALLAS TX 75230
Business Address
Herchuk Jannie Prestridge (Reporting) CIK: 0001973204 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34810 | Film No.: 23990716